The Board of Regents of The University of Texas System;The Board of Trustees of the University of Illinois
发明人:
HERGENROTHER, PAUL J.,BOOTHMAN, DAVID A.,BAIR, JOSEPH S.,PALCHAUDHURI, RAHUL
申请号：
PL12840771
公开号：
PL2768308T3
申请日:
2012.10.12
申请国别(地区):
PL
年份:
2018
代理人:
摘要：
Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
